These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9759782)

  • 1. Haemochromatosis and type 2 diabetes.
    Aldersley MA; Allgar V; Howdle PD; Markham AF
    Lancet; 1998 Sep; 352(9133):1067-8. PubMed ID: 9759782
    [No Abstract]   [Full Text] [Related]  

  • 2. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes.
    Frayling T; Ellard S; Grove J; Walker M; Hattersley AT
    Lancet; 1998 Jun; 351(9120):1933-4. PubMed ID: 9654270
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness.
    Adams PC; Kertesz AE; Valberg LS
    Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic hemochromatosis: importance of population screening?].
    Cartabellotta A; Montalto G
    Recenti Prog Med; 1996 Mar; 87(3):118-23. PubMed ID: 8650432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for hemochromatosis.
    Kushner JP
    Gastroenterology; 1995 Jul; 109(1):315-6. PubMed ID: 7797031
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for hereditary haemochromatosis within families and beyond.
    McCune CA; Ravine D; Worwood M; Jackson HA; Evans HM; Hutton D
    Lancet; 2003 Dec; 362(9399):1897-8. PubMed ID: 14667749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longevity and C282Y mutation for haemochromatosis: survival of C282Y homozygotes does not preclude screening for HFE mutations.
    Willis G; Jennings BA; Wimperis JZ
    BMJ; 2003 Oct; 327(7421):990-1; author reply 991. PubMed ID: 14576264
    [No Abstract]   [Full Text] [Related]  

  • 8. Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene.
    Kwan T; Leber B; Ahuja S; Carter R; Gerstein HC
    Clin Invest Med; 1998 Dec; 21(6):251-7. PubMed ID: 9885759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preclinical hereditary hemochromatosis--is there an indication for preventive screening?].
    Grønbaek KE; Milman N; Skødt V
    Ugeskr Laeger; 1995 Jul; 157(30):4249-50. PubMed ID: 7653009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older.
    Baer DM; Simons JL; Staples RL; Rumore GJ; Morton CJ
    Am J Med; 1995 May; 98(5):464-8. PubMed ID: 7733125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hemochromatosis N144H mutation of SLC11A3 gene in patients with type 2 diabetes.
    Njajou OT; Vaessen N; Oostra B; Heutink P; Van Duijn CM
    Mol Genet Metab; 2002 Mar; 75(3):290-1. PubMed ID: 11914044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of hereditary haemochromatosis--identify an affected person and save a family.
    Milani MY; Kotze MJ
    S Afr Med J; 1999 Mar; 89(3):263-4. PubMed ID: 10226670
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for hemochromatosis?
    Lederle FA
    J Gen Intern Med; 1989; 4(1):61-3. PubMed ID: 2915275
    [No Abstract]   [Full Text] [Related]  

  • 15. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.
    Gagné G; Reinharz D; Laflamme N; Adams PC; Rousseau F
    Clin Genet; 2007 Jan; 71(1):46-58. PubMed ID: 17204047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemochromatosis.
    Wkly Epidemiol Rec; 1996 Nov; 71(46):349-50. PubMed ID: 8961811
    [No Abstract]   [Full Text] [Related]  

  • 18. High prevalence of the Cys282Tyr HFE mutation facilitates an improved diagnostic service for hereditary haemochromatosis in South Africa.
    de Villiers JN; Hillerman R; de Jong G; Langenhoven E; Rossouw H; Marx MP; Kotze MJ
    S Afr Med J; 1999 Mar; 89(3):279-82. PubMed ID: 10226674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New knowledge of genetic pathogenesis of hemochromatosis and Wilson's disease.
    Bacon BR; Schilsky ML
    Adv Intern Med; 1999; 44():91-116. PubMed ID: 9929706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should we screen for hemochromatosis? Critical analysis of the literature].
    Charvet-Protat S; Yaouanq J; Fleurette F
    Rev Epidemiol Sante Publique; 1997 Sep; 45(4):315-27. PubMed ID: 9380912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.